Literature DB >> 22588953

Subclinical hypercortisolism: debatable or visible on the lightbox?

Dimitra A Vassiliadi, Stylianos Tsagarakis.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22588953     DOI： 10.1007/s12020-012-9689-9

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  9 in total

Review 1.  Subclinical Cushing's syndrome: definition and management.

Authors:  M Terzolo; A Pia; G Reimondo
Journal:  Clin Endocrinol (Oxf)       Date:  2012-01       Impact factor: 3.478

2.  Is subclinical Cushing's syndrome an entity or a statistical fallout from diagnostic testing? Consensus surrounding the diagnosis is required before optimal treatment can be defined.

Authors:  Paul M Stewart
Journal:  J Clin Endocrinol Metab       Date:  2010-06       Impact factor: 5.958

Review 3.  Endogenous subclinical hypercortisolism: Diagnostic uncertainties and clinical implications.

Authors:  S Tsagarakis; D Vassiliadi; N Thalassinos
Journal:  J Endocrinol Invest       Date:  2006-05       Impact factor: 4.256

Review 4.  Endocrine incidentalomas--challenges imposed by incidentally discovered lesions.

Authors:  Dimitra A Vassiliadi; Stylianos Tsagarakis
Journal:  Nat Rev Endocrinol       Date:  2011-06-28       Impact factor: 43.330

5.  High prevalence of subclinical hypercortisolism in patients with bilateral adrenal incidentalomas: a challenge to management.

Authors:  Dimitra A Vassiliadi; Georgia Ntali; Eirini Vicha; Stylianos Tsagarakis
Journal:  Clin Endocrinol (Oxf)       Date:  2011-04       Impact factor: 3.478

6.  Subclinical hypercortisolism and CT appearance in adrenal incidentalomas: a multicenter study from Southern Sweden.

Authors:  Henrik Olsen; Erik Nordenström; Anders Bergenfelz; Ulf Nyman; Stig Valdemarsson; Erik Palmqvist
Journal:  Endocrine       Date:  2012-02-17       Impact factor: 3.633

7.  Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas.

Authors:  S Tsagarakis; C Roboti; P Kokkoris; V Vasiliou; C Alevizaki; N Thalassinos
Journal:  Clin Endocrinol (Oxf)       Date:  1998-08       Impact factor: 3.478

Review 8.  Incidentally discovered adrenal masses.

Authors:  R T Kloos; M D Gross; I R Francis; M Korobkin; B Shapiro
Journal:  Endocr Rev       Date:  1995-08       Impact factor: 19.871

9.  Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink?

Authors:  T J Cawood; P J Hunt; D O'Shea; D Cole; S Soule
Journal:  Eur J Endocrinol       Date:  2009-05-13       Impact factor: 6.664
  9 in total
  3 in total

1.  Concordance of the late night salivary cortisol in patients with Cushing's syndrome and elevated urine-free cortisol.

Authors:  Suhail A R Doi; Justin Clark; Anthony W Russell
Journal:  Endocrine       Date:  2012-12-14       Impact factor: 3.633

2.  Epicardial fat thickness and left ventricular mass in subjects with adrenal incidentaloma.

Authors:  Gianluca Iacobellis; Luigi Petramala; Giuseppe Barbaro; Atil Y Kargi; Valentina Serra; Laura Zinnamosca; Luciano Colangelo; Cristiano Marinelli; Antonio Ciardi; Giorgio De Toma; Claudio Letizia
Journal:  Endocrine       Date:  2013-02-21       Impact factor: 3.633

3.  DHEAS for the prediction of subclinical Cushing's syndrome: perplexing or advantageous?

Authors:  Serkan Yener; Hamiyet Yilmaz; Tevfik Demir; Mustafa Secil; Abdurrahman Comlekci
Journal:  Endocrine       Date:  2014-08-22       Impact factor: 3.633
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.